Intraepidermal nerve fiber loss corresponds to the development of taxol-induced hyperalgesia and can be prevented by treatment with minocycline
about
Chemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspectiveMechanisms involved in the development of chemotherapy-induced neuropathyMechanisms of chemotherapy-induced behavioral toxicitiesAstrocytes, but not microglia, are activated in oxaliplatin and bortezomib-induced peripheral neuropathy in the ratThe anti-diabetic drug metformin protects against chemotherapy-induced peripheral neuropathy in a mouse modelCXCR1/2 pathways in paclitaxel-induced neuropathic painEnhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathyNorth Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled studyPathophysiology of Chemotherapy-Induced Peripheral Neuropathy.Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy.Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy.Role of the DNA base excision repair protein, APE1 in cisplatin, oxaliplatin, or carboplatin induced sensory neuropathyPaclitaxel-induced hyposensitivity to nociceptive chemical stimulation in mice can be prevented by treatment with minocycline.A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapyProtection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline.Neurosteroid 3α-androstanediol efficiently counteracts paclitaxel-induced peripheral neuropathy and painful symptomsFollow-up psychophysical studies in bortezomib-related chemoneuropathy patients.Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat.Blocking the GABA transporter GAT-1 ameliorates spinal GABAergic disinhibition and neuropathic pain induced by paclitaxel.Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin.Sensory neuron subpopulation-specific dysregulation of intracellular calcium in a rat model of chemotherapy-induced peripheral neuropathy.Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of Paclitaxel-induced painful neuropathyMAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy.Multiple impairments of cutaneous nociceptor function induced by cardiotoxic doses of Adriamycin in the rat.The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4Translational approaches to treatment-induced symptoms in cancer patients.Minocycline blocks lipopolysaccharide induced hyperalgesia by suppression of microglia but not astrocytes.New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy.Rikkunshito prevents paclitaxel-induced peripheral neuropathy through the suppression of the nuclear factor kappa B (NFκB) phosphorylation in spinal cord of mice.Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristineSubclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapyAxon Transport and Neuropathy: Relevant Perspectives on the Etiopathogenesis of Familial Dysautonomia.Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons.Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-μ.Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral NeuropathyMinocycline attenuates bone cancer pain in rats by inhibiting NF-κB in spinal astrocytes.Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathyInhibition of glycogen synthase kinase 3β activity with lithium prevents and attenuates paclitaxel-induced neuropathic pain.CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain.
P2860
Q26777967-25ACEE63-9216-4354-A877-A1089166760EQ26824380-8BEB1909-2B19-4545-806F-9B8CCBE5104BQ26998870-20683A7F-92D3-4A08-B20C-100D35233AF1Q28390312-7E2D62F7-4D9C-4C4B-B30E-30B1FFD5ACD1Q28539926-FA988995-ED83-4D1C-B77B-39C128E53D1CQ33618624-B17ED16D-BCA7-4CD8-BBE4-987EF00896BBQ33650951-1A8C2BDE-B70A-444F-AF6B-43D456413237Q33717608-00270139-91E7-458F-AA37-649D8F6CE78FQ33744706-7A2A942C-6E39-4CB0-BFE0-62B18AA5756CQ33851825-DCCFA6F1-C010-4911-A1FC-5FFC9960D900Q34038073-5FDE04C7-D108-4A75-961E-1C8736F5EA5AQ34133825-C8FEE1BA-7733-4179-B78C-EF3769A8FEC0Q34384978-9A7530A5-BE6F-4E42-A581-80B8BF330223Q34438547-BD125F0F-294B-4528-BF53-D544400AE327Q35000576-A46682AE-6877-426C-A180-604B0AA4A38BQ35049356-B8F1D837-3A5E-4020-8F1D-7E7DE7E76990Q35188312-D1EBC9F1-BCF7-483A-91B9-AB9B9D036DB0Q35613627-C843F074-DD87-408C-BAAB-573602518B11Q35732644-75A3EB33-8EE0-438D-A328-05F1E831B5D2Q35784775-D49E410D-7762-4F6C-8218-4A3727E33937Q35798221-A9D5A0D6-871B-4093-9B6D-9F58AD420F12Q35803293-0A5E6939-5044-4A1E-825B-6E5FFF1F7980Q36053079-BD5ECDAC-5944-4FFC-931B-5C0259A9B59FQ36061374-A01F6082-21A3-49BA-A5B4-3E5B7BDDC054Q36106866-45100202-CC84-4BEC-88CA-C2E21E5D979DQ36143029-A977DD4B-8003-4BBF-B02C-2C5BE9F1DDD6Q36179484-2326A849-352B-44BB-B98B-5D2117F9A513Q36226275-979DA3B2-2E4B-462F-94A6-4AC7F262DD86Q36275592-60C0CE46-17B8-4169-B3C6-2DA6D840A03CQ36439933-9F12AE0F-F685-4F28-BA54-78C24FBEAAE6Q36636831-055D5249-2566-44E4-9F92-8F4F1DB35A10Q36748075-70AE3643-8442-416E-8C1F-E71BCDBB613CQ36753688-AFC201AC-D391-4CC6-BBF6-E58AEDB503ADQ36884527-4A4272FB-48DE-41F1-9D43-E1B7119BD3C0Q36988206-50841634-AE66-48A3-AB7B-3192573797C8Q37081502-7113A66C-99EE-4D56-8CE5-2CBD872377D4Q37112300-E9A151F5-826A-4138-943D-078C501A6727Q37216797-3AC9AEB8-7E3C-40C5-9848-39CACF773350Q37317816-77DC1035-536F-44AB-B2D3-F89EF778AB59Q37398478-D5860344-352E-4143-9463-CA4C6BDE7DB0
P2860
Intraepidermal nerve fiber loss corresponds to the development of taxol-induced hyperalgesia and can be prevented by treatment with minocycline
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Intraepidermal nerve fiber los ...... by treatment with minocycline
@ast
Intraepidermal nerve fiber los ...... by treatment with minocycline
@en
Intraepidermal nerve fiber los ...... by treatment with minocycline
@nl
type
label
Intraepidermal nerve fiber los ...... by treatment with minocycline
@ast
Intraepidermal nerve fiber los ...... by treatment with minocycline
@en
Intraepidermal nerve fiber los ...... by treatment with minocycline
@nl
prefLabel
Intraepidermal nerve fiber los ...... by treatment with minocycline
@ast
Intraepidermal nerve fiber los ...... by treatment with minocycline
@en
Intraepidermal nerve fiber los ...... by treatment with minocycline
@nl
P2093
P2860
P1433
P1476
Intraepidermal nerve fiber los ...... by treatment with minocycline
@en
P2093
P2860
P304
P356
10.1016/J.PAIN.2010.10.030
P407
P577
2010-12-09T00:00:00Z